Advertisement

Loading...

Mind Cure Health Inc.

MCUR.CNCNQ
Healthcare
Biotechnology
$0.07
$0.00(0.00%)
Canadian Market is Open • 12:49

Mind Cure Health Inc. Fundamental Analysis

Mind Cure Health Inc. (MCUR.CN) shows weak financial fundamentals with a PE ratio of -0.32, profit margin of 0.00%, and ROE of -1.61%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position123.75%
PEG Ratio-0.00
Current Ratio4.76

Areas of Concern

ROE-1.61%
Operating Margin0.00%
We analyze MCUR.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -163.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-163.9/100

We analyze MCUR.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

MCUR.CN struggles to generate sufficient returns from assets.

ROA > 10%
-2.48%

Valuation Score

Excellent

MCUR.CN trades at attractive valuation levels.

PE < 25
-0.32
PEG Ratio < 2
-0.00

Growth Score

Weak

MCUR.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MCUR.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.76

Profitability Score

Weak

MCUR.CN struggles to sustain strong margins.

ROE > 15%
-160.99%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is MCUR.CN Expensive or Cheap?

P/E Ratio

MCUR.CN trades at -0.32 times earnings. This suggests potential undervaluation.

-0.32

PEG Ratio

When adjusting for growth, MCUR.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Mind Cure Health Inc. at 0.99 times its book value. This may indicate undervaluation.

0.99

EV/EBITDA

Enterprise value stands at -1.12 times EBITDA. This is generally considered low.

-1.12

How Well Does MCUR.CN Make Money?

Net Profit Margin

For every $100 in sales, Mind Cure Health Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-1.61 in profit for every $100 of shareholder equity.

-1.61%

ROA

Mind Cure Health Inc. generates $-2.48 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.48%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

MCUR.CN converts -1.40% of its market value into free cash.

-1.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.32

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.76

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.61

vs 25 benchmark

ROA

Return on assets percentage

-2.48

vs 25 benchmark

ROCE

Return on capital employed

-0.83

vs 25 benchmark

How MCUR.CN Stacks Against Its Sector Peers

MetricMCUR.CN ValueSector AveragePerformance
P/E Ratio-0.3227.91 Better (Cheaper)
ROE-160.99%687.00% Weak
Net Margin0.00%-45285.00% (disorted) Weak
Debt/Equity0.000.33 Strong (Low Leverage)
Current Ratio4.762795.76 Strong Liquidity
ROA-248.04%-13557.00% (disorted) Weak

MCUR.CN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Mind Cure Health Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ